Your browser doesn't support javascript.
loading
Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn's Disease.
Osterman, Mark T; Gordon, Ilyssa O; Davis, Elisabeth M; Ciorba, Matthew; Glover, Sarah C; Abraham, Bincy; Khan, Freeha; Guo, Xueyan; Yee, Eric U; Allard, Felicia D; Claggett, Brian; Shen, Bo; Liu, Julia J.
Afiliação
  • Osterman MT; Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Gordon IO; Department of Pathology, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Davis EM; Division of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Ciorba M; Division of Gastroenterology and Hepatology, Washington University School of Medicine, St. Louis, MO, USA.
  • Glover SC; Division of Gastroenterology and Hepatology, University of Florida, Gainesville, FL, USA.
  • Abraham B; Division of Gastroenterology and Hepatology, Houston Methodist Hospital, Houston, TX, USA.
  • Khan F; Department of Gastroenterology, Hepatology, and Nutrition, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Guo X; Division of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Yee EU; Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Allard FD; Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Claggett B; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Shen B; Department of Gastroenterology, Hepatology, and Nutrition, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Liu JJ; Division of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Inflamm Bowel Dis ; 26(10): 1554-1561, 2020 09 18.
Article em En | MEDLINE | ID: mdl-31553433

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doença de Crohn / Anticorpos Monoclonais Humanizados / Imunidade Inata / Mucosa Intestinal Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Inflamm Bowel Dis Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doença de Crohn / Anticorpos Monoclonais Humanizados / Imunidade Inata / Mucosa Intestinal Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Inflamm Bowel Dis Ano de publicação: 2020 Tipo de documento: Article